Surface Oncology Inc.

NASDAQ: SURF · Real-Time Price · USD
1.07
-0.01 (-0.93%)
At close: Sep 07, 2023, 10:00 PM

Surface Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-63.59M -78.48M
Depreciation & Amortization
1.37M 1.57M
Stock-Based Compensation
7.22M 8.55M
Other Working Capital
-6.29M 2.33M
Other Non-Cash Items
3.03M 3.11M
Deferred Income Tax
n/a 807K
Change in Working Capital
-7.59M 2.11M
Operating Cash Flow
-59.55M -62.34M
Capital Expenditures
-497K -120K
Cash Acquisitions
n/a n/a
Purchase of Investments
-40.19M -111.63M
Sales Maturities Of Investments
63.45M 12.5M
Other Investing Acitivies
0.00 n/a
Investing Cash Flow
22.76M -99.25M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
31.66M 42.5M
Financial Cash Flow
31.66M 42.5M
Net Cash Flow
-5.13M -119.1M
Free Cash Flow
-60.05M -62.46M